Literature DB >> 2188307

CT of malignant anal canal tumors.

A Scherrer1, F Reboul, D Martin, J C Dupuy, Y Menu.   

Abstract

Radiation therapy of malignant neoplasms of the anal canal has promising results in the majority of patients if the disease is limited at initial diagnosis. Computed tomography (CT), especially when performed with contrast material injected intravenously, is valuable in the pre- and posttreatment assessment of the anorectal musculature and perirectal nodes. The authors review the anatomy of the anorectal area and their experience with CT evaluation of anal canal cancer in a series of 26 patients. They also discuss their experience with treatment of this cancer in a series of 48 patients.

Entities:  

Mesh:

Year:  1990        PMID: 2188307     DOI: 10.1148/radiographics.10.3.2188307

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  5 in total

1.  Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival.

Authors:  Letizia Deantonio; Maria Elisa Milia; Tiziana Cena; Gianmauro Sacchetti; Carola Perotti; Marco Brambilla; Lucia Turri; Marco Krengli
Journal:  Radiol Med       Date:  2015-07-01       Impact factor: 3.469

2.  Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma.

Authors:  Laetitia Vercellino; Françoise Montravers; Vincent de Parades; Virginie Huchet; Khaldoun Kerrou; Pierre Bauer; Emmanuel Touboul; Jean-Noël Talbot
Journal:  Int J Colorectal Dis       Date:  2011-02       Impact factor: 2.571

3.  Invasive squamous cell carcinoma of the anus arising in condyloma acuminatum: CT demonstration.

Authors:  P Goodman; R D Halpert
Journal:  Gastrointest Radiol       Date:  1991

Review 4.  Anorectal Cancer: Critical Anatomic and Staging Distinctions That Affect Use of Radiation Therapy.

Authors:  Shanna A Matalon; Harvey J Mamon; Charles S Fuchs; Leona A Doyle; Sree Harsha Tirumani; Nikhil H Ramaiya; Michael H Rosenthal
Journal:  Radiographics       Date:  2015 Nov-Dec       Impact factor: 5.333

5.  FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.

Authors:  F L Day; E Link; S Ngan; T Leong; K Moodie; C Lynch; M Michael; E de Winton; A Hogg; R J Hicks; A Heriot
Journal:  Br J Cancer       Date:  2011-07-26       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.